Indies Pharma Jamaica Limited (JMSE: INDIES)

Indies Pharma Jamaica Balance Sheet

Financials in millions JMD. Fiscal year is November - October.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jul 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019
Cash & Equivalents	185.77	256.68	234.63	187.74	313.65	114.78
Cash & Short-Term Investments	185.77	256.68	234.63	187.74	313.65	114.78
Cash Growth	-25.62%	9.40%	24.98%	-40.14%	173.26%	13.20%
Accounts Receivable	192.76	156.69	106.83	118.53	146.94	128.86
Other Receivables	31.08	2.96	3.46	7.42	17.8	28.04
Receivables	223.84	159.65	110.29	125.94	164.74	292.49
Inventory	308.39	170.38	175.51	222.6	146.52	156.94
Prepaid Expenses	-	110.65	57.61	36.31	57.49	3.03
Other Current Assets	38.85	26.33	41.02	0.76	70.21	56.56
Total Current Assets	756.85	723.7	619.06	573.35	752.61	623.8
Property, Plant & Equipment	927.62	968.36	949.4	979.87	228.47	137.13
Long-Term Investments	11	16.3	79.44	146.75	147.5	-
Other Intangible Assets	447.3	441.75	379.31	317.63	114.7	-
Long-Term Deferred Tax Assets	2.2	2.2	-	-	-	-
Other Long-Term Assets	82.97	87.87	21.01	18.94	444.38	9.98
Total Assets	2,228	2,240	2,048	2,037	1,688	770.91
Accounts Payable	12.25	35.64	16.31	34.87	57.13	54.29
Accrued Expenses	5.1	-	-	-	-	4.12
Short-Term Debt	6.3	11.99	7.86	3.44	6.15	8.26
Current Portion of Leases	34.19	34.19	1.22	46.58	35.86	-
Current Income Taxes Payable	23.44	15.74	-	-	-	-
Other Current Liabilities	8.78	45.27	35.08	13.32	21.84	9.01
Total Current Liabilities	90.05	142.84	60.48	98.2	120.98	75.67
Long-Term Debt	805	805	805	805	805	-
Long-Term Leases	19.7	50.92	1.25	-	41.19	-
Other Long-Term Liabilities	65.01	22.39	24.54	46.6	3.75	-
Total Liabilities	979.76	1,021	891.27	949.8	970.93	75.67
Common Stock	244.58	244.58	244.58	244.58	244.58	244.58
Retained Earnings	545.12	515.98	453.9	383.69	360.53	339.73
Comprensive Income & Other	458.48	458.48	458.48	458.48	111.62	110.92
Shareholders' Equity	1,248	1,219	1,157	1,087	716.73	695.23
Total Liabilities & Equity	2,228	2,240	2,048	2,037	1,688	770.91
Total Debt	865.19	902.1	815.33	855.02	888.2	8.26
Net Cash (Debt)	-679.41	-645.42	-580.7	-667.27	-574.55	106.52
Net Cash Growth	-	-	-	-	-	9.28%
Net Cash Per Share	-0.50	-0.48	-0.44	-0.50	-0.43	0.08
Filing Date Shares Outstanding	1,333	1,333	1,333	1,333	1,333	1,333
Total Common Shares Outstanding	1,333	1,333	1,333	1,333	1,333	1,333
Working Capital	666.79	580.87	558.59	475.15	631.63	548.12
Book Value Per Share	0.94	0.91	0.87	0.82	0.54	0.52
Tangible Book Value	800.88	777.3	777.65	769.12	602.03	695.23
Tangible Book Value Per Share	0.60	0.58	0.58	0.58	0.45	0.52
Land	-	765	792.7	792.7	27.7	27.7
Machinery	-	125.18	118.53	100.42	79.95	81.95
Leasehold Improvements	-	104.49	146.79	138.54	122.67	97.26

Source: S&P Capital IQ. Standard template. Financial Sources.